Effect of exogenous catecholamines on tumor necrosis factor alpha, interleukin-6, interleukin-10 and beta-endorphin levels following severe trauma

被引:19
作者
Batistaki, Chrysanthi [1 ]
Kostopanagiotou, Georgia [1 ]
Myrianthefs, Pavlos [2 ]
Dimas, Cleanthi [3 ]
Matsota, Paraskevi [1 ]
Pandazi, Aggeliki [1 ]
Baltopoulos, George [2 ]
机构
[1] Univ Athens, Attikon Hosp, Sch Med, Dept Anaesthesiol 2, Athens 12462, Greece
[2] Univ Athens, KAT Hosp, Sch Nursing, Intens Care Unit, Athens 14561, Greece
[3] Univ Athens, Attikon Hosp, Sch Med, Dept Biochem, Athens 12462, Greece
关键词
trauma; shock; cytokines; beta-endorphin; catecholamines;
D O I
10.1016/j.vph.2007.12.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytokines and endogenous opioids are mediators of the post traumatic inflammatory response. The aim of this study was to determine the effect of exogenous catecholamines on Tumor Necrosis Factor alpha (TNFa), interleukin-6 (IL-6), interleukin-10 (IL-10) and Beta(beta)-endorphin levels in patients with severe trauma, during the first 24 h after injury. Forty four traumatized patients with haemorrhage class III and IV were included in the study. Patients were divided in two groups: Group 1 (adrenergic, n = 22) and Group 2 (non adrenergic, n = 22), depending on the use of exogenous catecholamines. Blood samples were collected at 0, 2, 4 and 24 h time points. Baseline values were different between the two groups, but an altered pattern of release was observed for TNFa, IL-6, IL-10 and -endorphin levels in patients treated with catecholamines. ICU stay was longer for the adrenergic group, while survival after 1 month was significantly lower. Findings support an altered pattern of cytokine release during the early phase after trauma, probably due to catecholamine presence. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:85 / 91
页数:7
相关论文
共 40 条
[1]   Interleukin 10 (IL-10) regulation of tumour necrosis factor alpha (TNF-alpha) from human alveolar macrophages and peripheral blood monocytes [J].
Armstrong, L ;
Jordan, N ;
Millar, A .
THORAX, 1996, 51 (02) :143-149
[2]   Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS) [J].
Bone, RC .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (08) :680-687
[3]   Neuroendocrine pharmacology of stress [J].
Carrasco, GA ;
de Kar, LDV .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 463 (1-3) :235-272
[4]  
Cavun S, 2001, J PHARMACOL EXP THER, V297, P612
[5]   Cytokines in patients with polytrauma [J].
DeLong, WG ;
Born, CT .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2004, (422) :57-65
[6]  
Elenkov IJ, 2000, PHARMACOL REV, V52, P595
[7]   MODULATION OF LIPOPOLYSACCHARIDE-INDUCED TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION BY SELECTIVE ALPHA-ADRENERGIC AND BETA-ADRENERGIC DRUGS IN MICE [J].
ELENKOV, IJ ;
HASKO, G ;
KOVACS, KJ ;
VIZI, ES .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 61 (02) :123-131
[8]   OPIATE ANTAGONISTS - ROLE IN THE TREATMENT OF HYPOVOLEMIC SHOCK [J].
FADEN, AI ;
HOLADAY, JW .
SCIENCE, 1979, 205 (4403) :317-318
[9]   Is interleukin 6 an early marker of injury severity following major trauma in humans? [J].
Gebhard, F ;
Pfetsch, H ;
Steinbach, G ;
Strecker, W ;
Kinzl, L ;
Brückner, UB .
ARCHIVES OF SURGERY, 2000, 135 (03) :291-295
[10]   INTERLEUKIN-10 REDUCES THE RELEASE OF TUMOR-NECROSIS-FACTOR AND PREVENTS LETHALITY IN EXPERIMENTAL ENDOTOXEMIA [J].
GERARD, C ;
BRUYNS, C ;
MARCHANT, A ;
ABRAMOWICZ, D ;
VANDENABEELE, P ;
DELVAUX, A ;
FIERS, W ;
GOLDMAN, M ;
VELU, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :547-550